Highlights BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
42.65 ^CNY	-1.20%		+3.70%	-11.15%

04-26	BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023	04-15	CI
BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38%	03-01	MT
BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Wuxi AppTec Denies Ties to Military in Wake of US Draft Bill Targeting Chinese Biotech Firms	02-06	MT
Correction: GemPharmatech Responds to US Legislation Concerns	01-30	MT
BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23	CI
BGI Genomics to Acquire Health Management Firm; Shares Slump 6%	14/08/23	MT
BGI Genomics Co., Ltd. signed a share transfer agreement to acquire Shenzhen Huada Special Inspection Technology Co., Ltd. from Shenzhen BGI Hospital Management Holding Co., Ltd. for CNY 0.71 million.	11/08/23	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	11/08/23	CI
Bgi Genomics Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 7 June 2023	31/05/23	CI
Bgi Genomics Co., Ltd. Approves Cash Dividend for 2022	10/05/23	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2022	31/03/23	CI
BGI Genomics Co., Ltd. agreed to acquire 15.65% stake in BGI Shuji Biotechnology Co., Ltd. for CNY 55.2 million.	30/03/23	CI
BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia	29/03/23	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
BGI Genomics to Sue Former Business Partner Over Claims of Faulty PCR Tests	06/12/22	MT
EU renews order for Illumina to keep Grail as separate entity	28/10/22	RE
BGI Genomics Co., Ltd.'s Equity Buyback announced on October 27, 2021, has expired.	25/10/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

Highlights

Filters